Guangdong Hybribio Biotech Co Ltd
300639
Company Profile
Business description
Guangdong Hybribio Biotech Co Ltd is engaged in the Research, development, production, and sales of in vitro diagnostic products such as molecular diagnostic reagents and related instruments, and provision of related services.
Contact
D5-3-3-4 Community
High-tech Zone, North Area
Chaozhou Economic Development Experimental Zone
Guangdong Province
Chaozhou City521000
CHNT: +86 7682852923
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
1,990
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
stocks
ASX listed media giant drives strong earnings growth
Digital growth drives earnings beat for media share.
stocks
ASX real estate platform outperforms yet questions remain
Valuation remains a key concern despite strong August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,424.10 | 13.30 | -0.14% |
| CAC 40 | 8,719.82 | 4.89 | 0.06% |
| DAX 40 | 26,431.06 | 111.61 | 0.42% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,876.04 | 25.05 | -0.23% |
| HKSE | 25,937.49 | 269.46 | 1.05% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 66,970.22 | 1,363.51 | 2.08% |
| NZX 50 Index | 13,888.24 | 64.11 | 0.46% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,232.60 | 17.00 | -0.18% |
| SSE Composite Index | 3,966.59 | 26.56 | 0.67% |